Investment Thesis — NewMarket Corporation
The market overreacts to NewMarket's recent drawdown, extrapolating short-term margin compression as structural decline, while underestimating the company's pricing power and end-market resilience. Investors are missing the supply/demand inflection in specialty chemicals that will restore profitability faster than consensus expects.
Catalysts
- Contract repricing cycles enabling margin recovery
- Industry consolidation reducing competitive pressure
- Unexpected rebound in transportation sector demand
Risk Factors
- Prolonged input cost inflation
- Loss of key customer contracts
- Regulatory changes impacting specialty chemicals
Key Debates
NEU revenue growth turns positive by Q1 2025 from destocking end.
Operating margins hold above 25% through Q4 despite revenue drop.
NEU stock stabilizes within 5% by Q4 as growth bottom is priced in.